Compare ARDX & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | TNC |
|---|---|---|
| Founded | 2007 | 1870 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2014 | 1994 |
| Metric | ARDX | TNC |
|---|---|---|
| Price | $6.21 | $77.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $15.14 | ★ $79.00 |
| AVG Volume (30 Days) | ★ 3.0M | 296.9K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.36 |
| Revenue | $2,607,000.00 | ★ $1,137,600,000.00 |
| Revenue This Year | $37.75 | $5.77 |
| Revenue Next Year | $34.24 | $4.95 |
| P/E Ratio | ★ N/A | $32.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.50 | $60.18 |
| 52 Week High | $8.40 | $85.91 |
| Indicator | ARDX | TNC |
|---|---|---|
| Relative Strength Index (RSI) | 56.13 | 71.69 |
| Support Level | $5.49 | $73.45 |
| Resistance Level | $6.23 | $84.24 |
| Average True Range (ATR) | 0.24 | 2.28 |
| MACD | 0.10 | 1.56 |
| Stochastic Oscillator | 94.53 | 98.71 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.